These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 26254990)

  • 1. Ponatinib ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway.
    Qu Y; Zhang L; Kang Z; Jiang W; Lv C
    Pulm Pharmacol Ther; 2015 Oct; 34():1-7. PubMed ID: 26254990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
    Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
    Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
    Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
    Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
    J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
    Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
    J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation.
    Wang C; Song X; Li Y; Han F; Gao S; Wang X; Xie S; Lv C
    PLoS One; 2013; 8(8):e70725. PubMed ID: 23967091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo.
    Zhang L; Ji YX; Jiang WL; Lv CJ
    Braz J Med Biol Res; 2015 Jun; 48(6):545-52. PubMed ID: 25992646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells.
    Wang X; Gao JL; Zhao MM; Zhu HX; Tian YX; Li R; Jiang XH; Yu L; Tian JR; Cui JZ
    Int J Mol Med; 2018 Feb; 41(2):659-668. PubMed ID: 29207055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of sesamin on airway fibrosis in vitro and in vivo.
    Lin CH; Shen ML; Kao ST; Wu DC
    Int Immunopharmacol; 2014 Sep; 22(1):141-50. PubMed ID: 24978608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats.
    Song X; Liu W; Xie S; Wang M; Cao G; Mao C; Lv C
    Lab Invest; 2013 Nov; 93(11):1219-31. PubMed ID: 24042439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocatechuic aldehyde ameliorates experimental pulmonary fibrosis by modulating HMGB1/RAGE pathway.
    Zhang L; Ji Y; Kang Z; Lv C; Jiang W
    Toxicol Appl Pharmacol; 2015 Feb; 283(1):50-6. PubMed ID: 25582705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
    Qian W; Cai X; Qian Q; Zhang W; Wang D
    J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
    Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
    J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT.
    Wang YC; Liu JS; Tang HK; Nie J; Zhu JX; Wen LL; Guo QL
    Int J Mol Med; 2016 Oct; 38(4):1208-16. PubMed ID: 27513632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis.
    Shimbori C; Bellaye PS; Xia J; Gauldie J; Ask K; Ramos C; Becerril C; Pardo A; Selman M; Kolb M
    J Pathol; 2016 Oct; 240(2):197-210. PubMed ID: 27425145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells.
    Yang T; Chen M; Sun T
    Cell Physiol Biochem; 2013; 31(6):863-74. PubMed ID: 23817018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo.
    Wang Y; Li R; Chen L; Tan W; Sun Z; Xia H; Li B; Yu Y; Gong J; Tang M; Ji Y; Yuan S; Shanglong Yao ; Shang Y
    Shock; 2015 Nov; 44(5):496-502. PubMed ID: 26196843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
    Gao L; Jiang D; Geng J; Dong R; Dai H
    Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.